Cargando…
1796. Use of SARS-CoV-2 Antibody Tests by U.S. Infectious Disease Physicians: Qualitative Results of an Emerging Infections Network Survey, March 2022
BACKGROUND: Although clinical applications of SARS-CoV-2 antibody tests during the COVID-19 pandemic were limited to identifying recent/prior infection, how these tests were used for clinical management of COVID-19 patients is unknown. We consider US infectious disease (ID) physicians’ perceptions a...
Autores principales: | Santibanez, Scott S, Gundlapalli, Adi, Beekmann, Susan E, Uyeki, Timothy M, Satheshkumar, Panayampalli, Plumb, Ian D, David-Ferdon, Corinne, Polgreen, Philip M, McDonald, L Clifford, Jones, Jefferson M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677743/ http://dx.doi.org/10.1093/ofid/ofad500.1625 |
Ejemplares similares
-
Antimicrobial Agent Shortages: The New Norm for Infectious Diseases Physicians
por: Gundlapalli, Adi V, et al.
Publicado: (2018) -
Infectious Disease Physician Assessment of Hospital Preparedness for Ebola Virus Disease
por: Polgreen, Philip M., et al.
Publicado: (2015) -
Het vaccin anno 1796
por: Heynick, Frank
Publicado: (2021) -
Infectious Diseases Physicians’ Perspectives Regarding Injection Drug Use and Related Infections, United States, 2017
por: Rapoport, Alison B, et al.
Publicado: (2018) -
Transrectal Prostate Biopsy-Associated Prophylaxis and Infectious Complications: Report of a Query to the Emerging Infections Network of the Infectious Diseases Society of America
por: Johnson, James R., et al.
Publicado: (2015)